D. Hanahan and R. Weinberg, The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000.
DOI : 10.1016/S0092-8674(00)81683-9

L. Coussens and Z. Werb, Inflammation and cancer, Nature, vol.2, issue.6917, pp.860-867, 2002.
DOI : 10.1006/cyto.1996.0074

F. Balkwill, K. Charles, and A. Mantovani, Smoldering and polarized inflammation in the initiation and promotion of malignant disease, Cancer Cell, vol.7, issue.3, pp.211-217, 2005.
DOI : 10.1016/j.ccr.2005.02.013

M. Karin and F. Greten, NF-??B: linking inflammation and immunity to cancer development and progression, Nature Reviews Immunology, vol.100, issue.10, pp.749-759, 2005.
DOI : 10.1038/nri1703

W. Lin and K. M. , A cytokine-mediated link between innate immunity, inflammation, and cancer, Journal of Clinical Investigation, vol.117, issue.5, pp.1175-1183, 2007.
DOI : 10.1172/JCI31537

A. Ben-baruch, Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators, Seminars in Cancer Biology, vol.16, issue.1, pp.38-52, 2006.
DOI : 10.1016/j.semcancer.2005.07.006

M. Smyth, E. Cretney, M. Kershaw, and Y. Hayakawa, Cytokines in cancer immunity and immunotherapy, Immunological Reviews, vol.63, issue.1, pp.275-293, 2004.
DOI : 10.1182/blood.V99.4.1259

R. Kim, M. Emi, K. Tanabe, and K. Arihiro, Tumor-Driven Evolution of Immunosuppressive Networks during Malignant Progression, Cancer Research, vol.66, issue.11, pp.5527-5536, 2006.
DOI : 10.1158/0008-5472.CAN-05-4128

J. Hadden, Immunodeficiency and cancer: prospects for correction, International Immunopharmacology, vol.3, issue.8, pp.1061-1071, 2003.
DOI : 10.1016/S1567-5769(03)00060-2

E. Pikarsky, R. Porat, I. Stein, R. Abramovitch, S. Amit et al., NF-??B functions as a tumour promoter in inflammation-associated cancer, Nature, vol.2, issue.7007, pp.461-466, 2004.
DOI : 10.1006/scbi.2000.0360

M. Karin, Inflammation and cancer: the long reach of Ras, Nature Medicine, vol.267, issue.1, pp.20-21, 2005.
DOI : 10.1016/j.cell.2004.07.013

J. Bodmer, P. Schneider, and J. Tschopp, The molecular architecture of the TNF superfamily, Trends in Biochemical Sciences, vol.27, issue.1, pp.19-26, 2002.
DOI : 10.1016/S0968-0004(01)01995-8

M. Hahne, T. Kataoka, M. Schroter, K. Hofmann, M. Irmler et al., APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth, The Journal of Experimental Medicine, vol.188, issue.6, pp.1185-1190, 1998.
DOI : 10.1146/annurev.med.45.1.491

K. Kelly, E. Manos, G. Jensen, L. Nadauld, and D. Jones, APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death, Cancer Res, vol.60, pp.1021-1027, 2000.

H. Shu, W. Hu, and H. Johnson, TALL-1 is a novel member of the TNF family that is down-regulated by mitogens, J Leukoc Biol, vol.65, pp.680-683, 1999.

J. Gross, J. Johnston, S. Mudri, R. Enselman, S. Dillon et al., TACI and BCMA are receptors for a TNF homologue implicated in Bcell autoimmune disease, Nature, vol.404, issue.6781, pp.995-999, 2000.
DOI : 10.1038/35010115

P. Schneider, F. Mackay, V. Steiner, K. Hofmann, J. Bodmer et al., BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth, The Journal of Experimental Medicine, vol.85, issue.11, pp.1747-1756, 1999.
DOI : 10.1126/science.7537388

P. Moore, O. Belvedere, A. Orr, K. Pieri, D. Lafleur et al., BLyS: Member of the Tumor Necrosis Factor Family and B Lymphocyte Stimulator, Science, vol.285, issue.5425, pp.260-263, 1999.
DOI : 10.1126/science.285.5425.260

M. Gras, Y. Laabi, G. Linares-cruz, M. Blondel, J. Rigaut et al., BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes, International Immunology, vol.7, issue.7, pp.1093-1106, 1995.
DOI : 10.1093/intimm/7.7.1093

S. Dillon, J. Gross, S. Ansell, and A. Novak, An APRIL to remember: novel TNF ligands as therapeutic targets, Nature Reviews Drug Discovery, vol.114, issue.3, pp.235-246, 2006.
DOI : 10.1074/jbc.M305754200

A. Hatzoglou, J. Roussel, M. Bourgeade, E. Rogier, C. Madry et al., TNF Receptor Family Member BCMA (B Cell Maturation) Associates with TNF Receptor-Associated Factor (TRAF) 1, TRAF2, and TRAF3 and Activates NF-??B, Elk-1, c-Jun N-Terminal Kinase, and p38 Mitogen-Activated Protein Kinase, The Journal of Immunology, vol.165, issue.3, pp.1322-1330, 2000.
DOI : 10.4049/jimmunol.165.3.1322

F. Mackay and C. Ambrose, The TNF family members BAFF and APRIL: the growing complexity, Cytokine & Growth Factor Reviews, vol.14, issue.3-4, pp.311-324, 2003.
DOI : 10.1016/S1359-6101(03)00023-6

L. Ng, C. Mackay, and F. Mackay, The BAFF/APRIL system: life beyond B lymphocytes, Molecular Immunology, vol.42, issue.7, pp.763-772, 2005.
DOI : 10.1016/j.molimm.2004.06.041

A. Kato, A. Truong-tran, A. Scott, K. Matsumoto, and R. Schleimer, Airway Epithelial Cells Produce B Cell-Activating Factor of TNF Family by an IFN-??-Dependent Mechanism, The Journal of Immunology, vol.177, issue.10, pp.7164-7172, 2006.
DOI : 10.4049/jimmunol.177.10.7164

Z. Guan, W. Dan, Y. Shui, J. Ye, and S. Zhang, cDNA cloning, expression and bioactivity of porcine BAFF, Developmental & Comparative Immunology, vol.31, issue.12, pp.1211-1219, 2007.
DOI : 10.1016/j.dci.2007.03.006

F. Deshayes, G. Lapree, A. Portier, Y. Richard, P. Pencalet et al., Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor, Oncogene, vol.23, issue.17, pp.3005-3012, 2004.
DOI : 10.1038/sj.onc.1207350

C. Ware and . April, April and Baff Connect Autoimmunity and Cancer: Figure 1, The Journal of Experimental Medicine, vol.60, issue.11, pp.35-38, 2000.
DOI : 10.1084/jem.192.10.1453

K. Mccarty, . Jr, L. Miller, E. Cox, J. Konrath et al., Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies, Arch Pathol Lab Med, vol.109, pp.716-721, 1985.

M. Lopez-fraga, R. Fernandez, J. Albar, and M. Hahne, Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase, EMBO reports, vol.1, issue.8, pp.945-951, 2001.
DOI : 10.1093/embo-reports/kve198

S. Molloy, E. Anderson, F. Jean, and G. Thomas, Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis, Trends in Cell Biology, vol.9, issue.1, pp.28-35, 1999.
DOI : 10.1016/S0962-8924(98)01382-8

Y. Chicheportiche, P. Bourdon, H. Xu, Y. Hsu, H. Scott et al., TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis, Journal of Biological Chemistry, vol.272, issue.51, pp.32401-32410, 1997.
DOI : 10.1074/jbc.272.51.32401

B. Nardelli, O. Belvedere, V. Roschke, P. Moore, H. Olsen et al., Synthesis and release of B-lymphocyte stimulator from myeloid cells, Blood, vol.97, issue.1, pp.198-204, 2001.
DOI : 10.1182/blood.V97.1.198

M. Nakayama, N. Kayagaki, N. Yamaguchi, K. Okumura, and H. Yagita, Involvement of Tweak in Interferon ?????Stimulated Monocyte Cytotoxicity, The Journal of Experimental Medicine, vol.865, issue.9, pp.1373-1380, 2000.
DOI : 10.1016/S0923-2494(99)80036-4

C. Bossen and P. Schneider, BAFF, APRIL and their receptors: Structure, function and signaling, Seminars in Immunology, vol.18, issue.5, pp.263-275, 2006.
DOI : 10.1016/j.smim.2006.04.006

P. Dempsey, S. Doyle, J. He, and G. Cheng, The signaling adaptors and pathways activated by TNF superfamily, Cytokine & Growth Factor Reviews, vol.14, issue.3-4, pp.193-209, 2003.
DOI : 10.1016/S1359-6101(03)00021-2

J. Hendriks, L. Planelles, J. De-jong-odding, G. Hardenberg, S. Pals et al., Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation, Cell Death and Differentiation, vol.26, issue.6, pp.637-648, 2005.
DOI : 10.1038/sj.cdd.4401647

J. Esko and U. Lindahl, Molecular diversity of heparan sulfate, Journal of Clinical Investigation, vol.108, issue.2, pp.169-173, 2001.
DOI : 10.1172/JCI200113530

J. Gallagher, Heparan sulfate: growth control with a restricted sequence menu, Journal of Clinical Investigation, vol.108, issue.3, pp.357-361, 2001.
DOI : 10.1172/JCI13713

N. Perrimon and M. Bernfield, Specificities of heparan sulphate proteoglycans in developmental processes, Nature, vol.404, issue.6779, pp.725-728, 2000.
DOI : 10.1038/35008000

K. Ingold, A. Zumsteg, A. Tardivel, B. Huard, Q. Steiner et al., Identification of proteoglycans as the APRIL-specific binding partners, The Journal of Experimental Medicine, vol.103, issue.9, pp.1375-1383, 2005.
DOI : 10.1002/eji.1830221136

D. Sakurai, H. Hase, Y. Kanno, H. Kojima, K. Okumura et al., TACI regulates IgA production by APRIL in collaboration with HSPG, Blood, vol.109, pp.2961-2967, 2007.
DOI : 10.1182/blood-2006-08-041772

D. Bischof, S. Elsawa, G. Mantchev, J. Yoon, G. Michels et al., Selective activation of TACI by syndecan-2, Blood, vol.107, issue.8, pp.3235-3242, 2006.
DOI : 10.1182/blood-2005-01-0256

P. Mhawech-fauceglia, G. Kaya, G. Sauter, T. Mckee, O. Donze et al., The source of APRIL up-regulation in human solid tumor lesions, Journal of Leukocyte Biology, vol.80, issue.4, pp.697-704, 2006.
DOI : 10.1189/jlb.1105655

M. Bernfield, M. Gotte, P. Park, O. Reizes, M. Fitzgerald et al., Functions of Cell Surface Heparan Sulfate Proteoglycans, Annual Review of Biochemistry, vol.68, issue.1, pp.729-777, 1999.
DOI : 10.1146/annurev.biochem.68.1.729

A. Chiu, W. Xu, B. He, S. Dillon, J. Gross et al., Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL, Blood, vol.109, issue.2, pp.729-739, 2007.
DOI : 10.1182/blood-2006-04-015958

A. Schaffler, J. Scholmerich, and B. Salzberger, Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs, Trends in Immunology, vol.28, issue.9, 2007.
DOI : 10.1016/j.it.2007.07.003

W. Cawthorn, F. Heyd, K. Hegyi, and J. Sethi, Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/ TCF4(TCF7L2)-dependent pathway, Cell Death Differ, 2007.

C. Nelson-dooley, M. Della-fera, M. Hamrick, and C. Baile, Novel Treatments for Obesity and Osteoporosis: Targeting Apoptotic Pathways in Adipocytes, Current Medicinal Chemistry, vol.12, issue.19, pp.2215-2225, 2005.
DOI : 10.2174/0929867054864886